Last edition
News about Market
Pharmexcil’s iPHEX 2026 records USD 4.5-5 billion in potential business discussions, attracting buyers from 128 countries, with the next edition set for 2027.
Market | 11/09/2026 | By News Bureau | 158
OPPI Appoints Amitabh Dube as President for Two-Year Term
Amitabh Dube has been appointed President of OPPI for a two-year term effective September 10, 2026. He will lead OPPI’s efforts to advance innovation, healthcare access and collaboration across India’s pharmaceutical sector.
Market | 11/09/2026 | By News Bureau
HAB Pharma Appoints Pankaj Agarwal as Chief Financial Officer
Pankaj Agarwal’s appointment to strengthen HAB Pharma’s financial and organisational capabilities as it expands manufacturing capacity, R&D initiatives and domestic and international market opportunities.
Market | 11/09/2026 | By News Bureau
Renova Pharmaceuticals Launches First 3 US Generics
Renova Pharmaceuticals has launched its first 3 US generic products, marking a major milestone in its transition to a growing commercial presence in the US generics market.
Market | 11/09/2026 | By News Bureau
Galmed Pharmaceuticals Rebrands as EoCene, Adopts Ticker EOCN
Galmed Pharmaceuticals rebrands as EoCene with new ticker EOCN, terminates its Yorkville SEPA and regains Nasdaq minimum bid price compliance.
Market | 11/09/2026 | By News Bureau
MannKind and Rose Pharma Enter Global Collaboration to Develop Inhaled GLP-1 for Weight Management
MannKind and Rose Pharma have entered a worldwide collaboration to develop ROSE-010 Technosphere, an investigational rapid-acting inhaled GLP-1 therapy for weight management.
Market | 10/09/2026 | By News Bureau
Kaisha Pharma Establishes Global Business Development Hub in Italy
Kaisha Pharma has established Kaisha Pharma International in Italy to strengthen global business development, customer support and market engagement across key international pharmaceutical markets.
Market | 10/09/2026 | By News Bureau
Fermenta Biotech, VIT Vellore Ink Licence Deal for Natural Vitamin B12 Fortification Technology
Fermenta Biotech and VIT Vellore have entered an exclusive licence agreement to commercialise a technology for natural in-situ vitamin B12 fortification in fermented foods, with potential applications across FMCG, nutrition and nutraceutical segments.
Market | 10/09/2026 | By News Bureau | 159
HRV Pharma Invests INR 150 Crore to Expand Peptide and High-Potent API Capabilities
HRV Pharma invests INR 150 crore to expand peptide and high-potent Active Pharmaceutical Ingredient (API) capabilities, strengthening its position in high-value pharmaceutical segments.
Market | 08/09/2026 | By News Bureau
Aptar and Aceso Therapeutics Partner on Inhaled Antisense Therapy for Cystic Fibrosis
Aptar and Aceso Therapeutics collaborate to advance inhaled antisense therapy ACT-101 for cystic fibrosis through formulation development and device assessment.
Market | 08/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy